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Abstract
Background: Population ageing is increasing the number of people annually diagnosed with cancer worldwide,
once most types of tumours are age-dependent. High-quality healthcare in geriatric oncology requires a
multimodal approach and should take into account stratified patient outcomes based on factors other than
chronological age in order to develop interventions able to optimize oncology care.
This study aims to evaluate the Health Related Quality of Life in head and neck cancer patients and compare the
scores in geriatric and younger patients.
Methods: Two hundred and eighty nine head and neck cancer patients from the Oncology Portuguese Institute
participated in the Health Related Quality of Life assessment. Two patient groups were considered: the geriatric
(≥65 years old, n = 115) and the younger (45-60 years old, n= 174). The EORTC QLQ-C30 and EORTC QLQ-H&N35
questionnaires were used.
Results: Head and neck cancer patients were mostly males, 77.4% within geriatric group and 91.4% among
younger patients group.
The most frequent tumour locations were similar in both groups: larynx, oral cavity and oropharynx - base of the tongue.
At the time of diagnosis, most of younger male patients were at disease stage III/IV (55.9%) whereas the majority
of younger female patients were at disease stage I/II (83.4%). The geriatric patient distribution was found to be
similar in any of the four disease stages and no gender differences were observed.
We found that age (geriatrics scored generally worse), gender (females scored generally worse), and tumour site
(larynx tumours denounce more significant problems between age groups) clearly influences Health Related
Quality of Life perceptions.
Conclusions: Geriatric oncology assessments signalize age-independent indicators that might guide oncologic
geriatric care optimization. Decision-making in geriatric oncology must be based on tumour characteristics and
chronological age but also on performance status evaluation, co-morbidity, and patient reported outcomes
assessment.
Background
The United Nations Organization (UNO) considers the
period between 1975 and 2025 the ageing era, once
society is ageing and life expectancy is rapidly growing.
This progressive ageing of the worldwide population is
increasing the number of people annually diagnosed with
cancer once most types of tumours are age-dependent. In
Europe, sixty percent of new cancer cases and over
seventy percent of cancer deaths occur in patients aged
65 years and older [1,2].
Head and neck cancer is one of the sixth most preva-
lent worldwide neoplasm, with an estimated 900,000
new cases diagnosed annually. Independently of tumour
site (oral cavity, oropharynx, sinus and nose, salivary
glands, larynx), surviving patients experience a dete-
rioration of their basic functions affecting such impor-
tant functions as: breathing, mastication, salivating,
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any medium, provided the original work is properly cited.swallowing, speaking, senses (hearing, taste and smell).
Moreover, aesthetics appearance is perceived as pro-
foundly affecting their lives [3-7].
High-quality healthcare in geriatric oncology (GO)
requires a multimodal approach. The stratified patient
outcome based on factors other than chronological age
supports development of more effective interventions in
order to optimize oncology care.
Geriatric patients are often under-treated, largely
under-represented in cancer trials and do not receive
standard treatments because they are considered unfit
for treatment as a consequence of inaccurate estimation
of the operative risk [8-11].
Health Related Quality of Life (HRQoL) begun to be
considered as one of the hard end-points for clinical
and research in GO. Such assessment can promote bet-
ter patients selection and support treatment decisions. It
may provide new measures and interventions in order
to optimize the individual treatment plan and reducing
inappropriate age-related inequity found in healthcare
assessment [10,12,13].
The HRQoL assessment involves biological, psycholo-
gical and socio-cultural criteria in a multidimensional
perspective looking for well-being ageing indicators:
longevity, biological, social and mental health, social
competence and status, satisfaction, cognitive control
and efficiency, productivity, activity, income, family and
occupational roles and informal relations continuity.
Methodological problems elderly related - illiteracy, con-
comitant diseases, social disorders, unviable validated
instruments or trouble in question understanding -
make the assessment a true challenge [14,15].
HRQoL directed programs for GO professionals -
developed in a multidisciplinary approach and focused
on advanced research and clinical practice - could opti-
mize HRQoL of both patients and their relatives.
Indeed, essential factors are recognized as important
to expedite the progress and healthcare systems refining:
the need of dedicated investigators, continuous health
education planning and linkage efforts among compara-
tive and multidisciplinary groups [16-18].
This study aims to evaluate the HRQoL in head and
neck cancer patients (HNCP) and compare the scores in
geriatric and younger patients.
Methods
Ethics
The study was carried out in compliance with the
Helsinki Declaration. The methodology was previously
approved by the local research ethical committee and
all HNCP agreed to participate in the research
and gave their informed consent. The data were col-
lected for research purposes as part of the routine
evaluation.
Patients
From January 2010 to July 2010, consecutive outpatients
- 3-9 months after first treatment completion- admitted
to the Otorhinolaringology and Head and Neck Services
(ORL and H&N service) IPO-Porto, Portugal, were
invited to participate in the HRQoL assessment protocol
of ORL and H&N Services. 289 patients were assessed
and questionnaires were completed immediately before
consultation as a part of the routine evaluation. Inclu-
sion criteria were ability to understand written and spo-
ken Portuguese and provision of written consent.
According to literature 65 years old is frequently con-
sidered a significant mark along the ageing process com-
monly overlapping retirement. In order to understand
the influence of age in HRQoL patients were divided
into two groups: the geriatric patients - GP (≥ 65 years
old, n = 115) and younger patients - YP (45-60 years
old, n = 174).
Socio-demographic and clinical data
Clinical data - such as tumour diagnosis and location,
tumour staging, tobacco habits, feeding type and pre-
sence of traqueostomy - as well socio-demographic data
- age and gender - were collected from the patient’s
clinical process and complemented, when needed, in
semi structured interviews.
Questionnaires
Quality of Life of HNCP was assessed using the Eur-
opean Organization for Research and Treatment of Can-
cer Quality of Life Questionnaire-Core 30 (EORTC
QLQ-C30) and the European Organization for Research
and Treatment of Cancer Quality of Life Questionnaire
Head and Neck Cancer Module (EORTC QLQ-H&N35)
- Portuguese version.
The EORTC QLQ-C30 (version 3.0) is a questionnaire
developed to assess the HRQoL of cancer patients. It
consists of 30 questions: twenty four form nine multi-
item scales presenting various aspects of HRQoL: five
functional scales (PF, Physical functioning; SF, Social
functioning; EF, Emotional functioning; RF, Role func-
tioning; CF, Cognitive functioning), three symptom
scales (fatigue, pain, nausea and vomiting) and a global
condition (health and quality of life). The remaining six
are single-item scales describing different cancer rele-
vant symptoms. During the scoring procedure, raw
EORTC QLQ-C30 scores are linearly transformed into 0
e100 scales. For global health status and the five func-
tioning scales, a score of 100 corresponds to a high
HRQoL. For financial difficulties and the eight symp-
toms, a score of 100 implies maximum difficulty or
symptom burden. The additional module - QLQ-
H&N35 (version 3.0) - is disease-specific for head and
neck patients. It consists of 35 questions organized in
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tions are presented) and eleven are single-item scales
describing different specific concerns of these head and
neck cancer patients.
Analysis Strategies and Statistics
Completed questionnaires were scored according to the
developers’ instructions.
HRQoL data were analyzed by the Statistical Package for
Social Sciences (SPSS), version 17 for windows. Descrip-
tive data are presented with means, standard deviations,
medians, ranges, and proportions as appropriate.
Results
Patients Characteristics
Male HNCP constituted the majority in the overall
(77.4%), particularly in theY Pg r o u pw h e r et h e yr e p r e -
sented 91.4% (Table 1).
The most frequent tumour locations were the larynx,
oral cavity and oropharynx - base of the tongue in both
groups: 29.6%, 12.6%, and 12.6% for GP and 31.4%,
16.2% and 10.6% for YP respectively.
At the time of diagnosis, most YP males were at dis-
ease stage III/IV (55.9%) whereas the majority of YP
females were at disease stage I/II (83.4%). YP group
were treated with surgery (71.4%), radiotherapy-RT
(7.6%), chemotherapy-CT (9.7%), and RT + QT (11.3%);
the GP were treated with surgery (79.1%), RT (14.3%),
CT (2%), and RT + QT (4.6%).
The GP gender distribution along disease stages dis-
ease was uniform. The tobacco habits inquiry revealed
that males are predominantly ex-smokers and females
are mostly non smokers being this tendency more evi-
dent in geriatric female patients (Figures 1 and 2).
Most HNCP were normally feed in both groups but
when considering non-oral feeding, PEG tube feeding
was always the major choice particularly found in the
GP group (Table 2).
EORTC QLQ-C30 and QLQ-H&N35
EORTC QLQ-C30 data are shown in Table 3. The ger-
iatric HNCP scored worse compared with the younger
sample on the functional scales: Physical, Cognitive and
Emotional. The differences obtained in Physical and
Emotional functioning were both clinically (difference
≥10 points) and statistically significant.
Male GP presented a worse score in all single items
and symptoms scales examined - dyspnoea (22), insom-
nia (31), constipation (21), diarrhoea (9), and fatigue
(29). On the contrary, financial difficulties (29), appetite
loss (24), and nausea and vomiting (17) caused a greater
negative impact in younger HNCP (40-60 years old),
mainly in females HNCP. The Standard Deviation (SD)
values show that the sample is very heterogeneous in all
the parameters evaluated.
Similar outcomes were observed for Global Health
Status/QoL in all subpopulations, around 58 points,
with lower scores found in geriatric females HNCP (54).
QLQ-H&N35 data are shown in Table 4. The female
HNCP aged 40-60 years old scored considerably worse
in most domains. The exceptions focused on Swallowing
(23), and Sticky saliva (37) that obtained inferior scores
in geriatric males, Coughing (29) with poor results in
males aged 40-60 years old and Dry Mouth (48) with
lower outcomes in geriatric females.
Tumour location
When EORTC QLQ-C30 scores are compared according
to tumour location and age, iti sv e r i f i e dt h a ti nL a r y n x
tumours, GP reveal worse values. For all subpopulations
considered, Physical (70), and Role functioning (75),
Constipation (22) and Fatigue (33) revealed the lowest
values. Oral Cavity analysisd e m o n s t r a t e st h a ty o u n g e r
HNCP had poor results in Social Functioning (80),
Diarrhoea (10) and Financial Difficulties (30). HNCP aged
40-60 years old with Pharynx (base of the tongue) cancer
reveal a negative impact in HRQoL in several domains in
opposition to the GP that appointed Physical (71) and
Cognitive Functioning (78) as the worst domains.
The EORTC QLQ-H&N 35 scores identified GP with
Larynx cancer as expressing poor score in all HRQoL
domains with the exceptions of Dry Mouth and Felling
Ill. The differences between geriatric and YP were found
significant in the Swallowing (29 to 17), Speech (34 to
42), Eating (16 to 28), Social Contact (13 to 21), Sexual-
ity (17 to 44) Scales, and Teeth Problems (17 to 33).
Considering Oral cancer, no significant differences were
found between these groups, except the single item:
Teeth Problems that scored worse in geriatric HNCP
(15 to 33). When Pharynx (base of the tongue) cancer is
considered, there are not significant differences between
older and younger cancer patients, with scores lightly
Table 1 Socio-demographic characteristics of HNCP (Age/Gender)
Age groups n = 284 Gender - Number of subjects (%)
40-60 ≥ 65 Male Female
40-60 ≥ 65 Male Female Male Female 40-60 ≥ 65 40-60 ≥ 65
174 (59.5%) 115 (40.5%) 159 (91.4) 15 (8.6) 89 (77.4) 26 (22.6) 159 (64.1) 89(35.9) 15 (36.6) 26 (63.4)
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focused on Speech (34 to 21), Open Mouth (28 to 18),
Laughing (40 to 11), and Felt Ill (27 to 13), were found
to be quite inferior in patients aged 40-60 years old.
Discussion
Head and neck cancer occurs mainly between the fifth and
sixth age decade, being the number of elderly HNC rising as
the result of demographic changes. Aged patients are predis-
posed to spontaneous mutations and hypomethylation of
the DNA, important predisposition factors for tumour cell
transformation and oncogen activation and thus favouring
tumour development. Actually, it is observed an increase of
head and neck cancer in geriatric population [9,19].
The participants, all from North of Portugal, are
mainly males (86%) and mostly young (64%). Such gen-
der asymmetry seems to be associated with cumulative
risk factors exposure (oral hygiene, dental status, oral
mucosal lesions, alcohol and tobacco use, virus infection
and lifestyle). Moreover, the spontaneous mutations
aged-related may have different expression in males and
females [20,21].
Considering tumour location, our data are in agree-
ment with literature identifying oral cavity, oropharynx,
hypopharynx, and larynx as the most common sites for
head and neck cancer [22]. Furthermore, the more pre-
valent stages found were III and IV in males and II and
III in females. Age seems not interfere in this tendency.
Figure 1 Socio-demographic and clinical characteristics of HNCP (Age/Gender/Tumour Staging).

Figure 2 Socio-demographic and clinical characteristics of HNCP (Age/Gender/Tobacco Habits).
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and smokers and female HNCP are mainly non smokers.
This corroborates other findings showing that men are
more likely than women to be current smokers [23-26].
Head and neck cancer is an extremely distressing dis-
ease disturbing anatomy and physiology of cervicofacial
region and affecting important functions - vision, hear-
ing, balance, olfaction, taste, mastication, swallowing,
breathing, voice - endocrine balance and body image.
Consequently, when considering HNCP, the impact of
the diagnosis and treatment on the multidimensional
patient outcomes need the most serious consideration.
Accordingly, HRQoL assessment in head and neck can-
cer is essential to know the HNCP perceptions.
Derks (2004) evaluated seventy-eight older (> or =
70 years) and 105 younger HNCP (45-60 years) and
referred that before and after treatment, the physical func-
tioning of the older was worse than that of YP [27]. Fang
(2010) described that pretreatment HRQoL variables from
patients with nasopharyngeal carcinoma, provided avail-
able prognostic value for distant metastasis and survival,
particularly physical functioning. Additionally, other
studies support the correlation of patient reported HRQoL
scales with survival in head and neck cancer [28,29].
Infante-Cossio reported in 2009 that HRQoL seemed
to be associated with age, indicating that HNCP under
65 years scored better [30]. Our results corroborate
these findings demonstrating that geriatric HNCP glob-
ally scored worse. The YP revealed more problems
related to Financial Difficulties, Appetite Loss, and Nau-
sea and Vomiting.
Results from the QLQ-H&N35 revealed YP female
scored considerably worse in the majority of the
domains - these findings are similar with those
described in literature identifying advanced tumour
stage, female gender, and long-term follow-up as the
factors that adversely affect HRQoL in HNCP [30,31].
The Global Health Status/QoL remains generally com-
parable between groups and according to van der
Schroeff (2007) who found no significant differences
between older and younger HNCP when considering
survival or overall HRQoL [32].
HRQoL scores revealed to be associated with tumour
location and age: Larynx tumours reveal more problems in
GP when considering Physical, Role functioning, Constipa-
tion and Fatigue. Oral Cavity analysis indicated that
younger HNCP had poor scores in Social Functioning,
Diarrhoea and Financial Difficulties. Unexpectedly, YP
with Pharynx cancer (base of the tongue) revealed a nega-
tive HRQoL impact in several domains - the opposite of
GP that scored better in almost all domains.
The EORTC QLQ-H&N 35 scores identified that GP
with Larynx cancer have poor results in all HRQoL
domains. In Oral and Pharynx cancers (base of the
Table 2 Socio-demographic and clinical characteristics of
HNCP (Age/Feeding/Traqueostomy)
Age Feeding
No. of subjects (%)
Traqueostomy
No. of subjects (%)
Oral
feeding
PEG
tube
Nasogastric
tube
Yes No
40-
60
154 (88.5) 8 (10.6) 4 (1.0) 23 (21.9) 82 (78.1)
≥ 65 92 (92.8) 11 (4.8) 1 (2.4) 38 (23.3) 125 (76.7)
Table 3 Results from the EORTC QLQ-C30 for subgroups of HNCP (Gender/Age)
EORTC QLQ C30 Male Female
40-60
(n = 159)
% (SD)
≥ 65
(n = 89)
% (SD)
40-60
(n = 15)
% (SD)
≥ 65
(n = 26)
% (SD)
Functional Scales Physical functioning 79 (18) 72 (25) 83 (19) 68 (23)
Role functioning 82 (26) 79 (30) 78 (30) 79 (26)
Cognitive functioning 85 (22) 79 (23) 79 (28) 78 (24)
Emotional functioning 78 (21) 75 (26) 62 (32) 69 (23)
Social functioning 85 (23) 85 (21) 82 (32) 85 (22)
Single Items Dyspnoea 17 (28) 22 (29) 9 (27) 10 (18)
Insomnia 25 (30) 31 (37) 29 (33) 20 (27)
Appetite loss 18 (29) 22 (33) 24 (37) 21 (31)
Constipation 10 (24) 21 (32) 13 (28) 14 (25)
Diarrhoea 6 (15) 9 (24) 0 3 (13)
Financial Difficulties 29 (35) 14 (25) 22 (35) 14 (21)
Symptoms Scales Fatigue 27 (24) 29 (24) 27 (28) 26 (21)
Nausea and vomiting 6 (14) 4 (10) 17 (28) 5 (12)
Pain 25 (28) 25 (30) 26 (26) 23 (23)
Global Health Status/QoL 59 (26) 59 (22) 59 (25) 54 (23)
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considered groups, being the scores lightly better in GP.
Presently, significant uncertainty exists in GO. The GP
often do not receive aggressive therapy regimens as a
consequence of imprecise evaluation of the operative
risk. A comprehensive geriatric assessment and team
approach may contribute to the identification of many
previously unmet problems, allowing then better strate-
gies planning in order to improve health outcomes [33].
There is almost an international consensus that HNCP
should be treated with curative intention and aggressive
treatment option should not be excluded [34,35]. Geria-
tric HNCP should be considered to receive standard
treatment - in fact previous studies reveal that therapy
associated complications do not occur significantly more
often in these patients. Age alone should not be the
basis for therapeutic planning and decision-making in
geriatric HNCP [9,36,37].
HRQoL assessment has been introduced as one of the
hard end-points in GO. Survival remains the most sig-
nificant end point and a HRQOL evaluation should be
thus a secondary end point. In fact, an EORTC ques-
tionnaire module for older people with cancer was
recently developed, the EORTC QLQ-ELD15. Such
questionnaire is prepared for large-scale studies in com-
bination with EORTC QLQ-C30 [38,39].
HRQoL assessment should be integrated in the com-
prehensive geriatric assessment procedure in order to
meet the GO healthcare professional’si m p r o v e m e n t
expectations [8,18,39].
Conclusions
Worldwide oncology programs have been developed for
the individualized management of HNCP in a multidi-
mensional and multidisciplinary way.
This study reveals that geriatric HNCP globally scored
worse in HRQoL assessment. Additionally advanced
tumour stage, female gender, and long-term follow-up
are variables that adversely affect HRQoL in HNCP.
Therapeutic planning and decision-making in Head
and Neck Cancer must be based not only on tumour
characteristics and chronological age, but also on perfor-
mance status evaluation, co-morbidity and patient
reported outcomes assessment. These outcomes asso-
ciated with comprehensive HNCP assessment aims to
screen unmet problems, contributing as prognosis pre-
dictors, substantiating the decision process, and redu-
cing age-related inequity. These assessments are
signalizing age-independent indicators that do optimize
oncologic geriatric care.
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